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ABSTRACT 
Specific binding of [3H]MK801 to N-methyl-D-aspartate (NMDA) receptors in the 
frontal cortex and hippocampus (CA1 and gyrus dentatus) was measured by 
receptor autoradiography in 16 Caucasian chronic alcohol consumers free of 
clinical manifestations of alcoholism, and compared to 16 Caucasian control 
subjects. Binding densities were not significantly different between heavy and 
moderate drinkers, neither between alcohol consumers that were abstinent or 
non-abstinent before death, nor between ethanol drinkers and controls. 
Continued alcohol consumption, in the absence of hepatic, neurologic or 
psychiatric disorders related to alcoholism, does not alter the binding properties 
of NMDA receptors in the brain areas studied.  
 
Running head short title: “NMDA receptors in alcohol consumers” 
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A number of studies have suggested that, at least partially, alcohol-induced 
brain damage associated to chronic alcohol consumption is mediated through 
changes in glutamatergic NMDA receptors. This is supported, by the effects of 
drugs such as acamprosate, a partial NMDA antagonist used in relapse 
prevention in alcohol-dependent patients (Hammarberg et al., 2009). Only few 
studies have addressed the analysis of glutamate receptors in relation to 
alcohol abuse in humans and have provided controversial results (Cummings et 
al. 1990; Dodd et al. 1992; Freund & Anderson 1996, 1999; Ridge et al. 2008). 
Our hypothesis is that permanent neuronal damage produced by chronic 
alcohol consumption is in part due to progressive changes in NMDA receptors, 
and that these changes might develop before the beginning of clinical 
manifestations of chronic alcoholism, including dependence, craving and 
abstinence. Thus, we assessed here the density of NMDA receptors in frontal 
cortex and hippocampus –brain areas known to be notably affected by chronic 
alcohol consumption– in a group of 16 alcohol consumers (AC) (16 male, mean 
age 58±12 years, post-mortem delay 19±8 hours) in comparison to a control 
group of 16 non-drinkers (14 male and 2 female, mean age 60±12 years, post-
mortem delay 17±5 hours) using autoradiographic techniques with the specific 
NMDA-antagonist [3H]MK801. AC subjects included had not suffered any 
hepatic, neurologic or psychiatric disorders related to alcoholism. They were 
classified as moderate consumers (40 to 80 g of absolute alcohol daily for at 
least 10 years) or heavy consumers (more than 80 g of absolute alcohol daily 
for at least 10 years, enough to develop chronic alcoholic pathology). We also 
discriminated between AC cases that were abstinent (alcohol withdrawal 
minimum one week before death) or non-abstinent (last ethanol ingestion less 
than 12 hours before death). In consequence, it is unlikely that these subjects 
would undergo a withdrawal situation that could eventually involve acute 
changes in NMDA receptors (See Supplementary Material for additional 
information).  
Densities of [3H]MK-801 binding were measured by microdensitometry on film 
autoradiograms in frontal cortex (layers II-VI), and CA1 (oriens and pyramidal 
layers) and gyrus dentatus (GD, molecular layer) of the hippocampus (Fig. 1), 
and are summarized in Table 1. Statistical analysis (unpaired t-test, GraphPad 
Prism) revealed the absence of significant differences between the different 
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groups analyzed. Covariance analysis (SPSS for Windows) indicated no 
influence of liver fibrosis in our sample (See Supplementary Material for 
detailed data). 
Our results suggest that binding to frontal cortex and hippocampal NMDA 
receptors remains unaltered after chronic consumption of high doses of alcohol 
in the absence of clinical manifestations of alcoholism. Previous studies on 
hippocampal homogenates reported higher densities of [3H]glutamate binding in 
5 alcoholics compared to 3 controls, with concomitant decreases in specific 
NMDA binding (Michaelis et al. 1990, 1993). Other authors (Dodd et al. 1992) 
found no differences in [3H]MK801 binding in cortical membrane preparations 
between 10 alcoholics and 6 controls. Finally, Ridge et al. (2008) detected 
decreases in the expression of NR1, NR2A and NR2B NMDA receptor subunits 
in cerebral cortex only in cirrhotic alcoholics, but not in alcoholics without 
hepatic disease. Using receptor autoradiography, Freund & Anderson (1996, 
1999) found significant increments in binding in frontal cortex (13 abstinent 
alcoholics and 13 controls) when using [3H]glutamate and the selective NMDA 
antagonist [3H]CGP39653. On the contrary, Cummins et al. (1990) showed 
reduced [3H]glutamate binding in hippocampus from 10 abstinent  alcoholics. 
Different reasons could explain the discrepancies between those data and our 
study. Clinical variations related to comorbidity such sudden death, cirrhosis, 
acute hypoxia or pneumonia could eventually alter glutamate binding (Piggott et 
al. 1992; Freund & Anderson 1996; Ridge et al. 2008). In our sample, we did 
not find an influence of liver fibrosis (a necropsy finding without previous clinical 
manifestations), supporting the study of Ridge et al. (2008) that suggests that 
hepatopathy, but not alcohol per se, could be the cause of changes in NMDA 
receptors.  
Another possible explanation is related to the ligand used. MK-801 binds inside 
the previously opened ion channel of the NMDA receptor and it has been 
demonstrated that ethanol diminishes [3H]MK801 binding only in the absence of 
glycine, a modulator of channel aperture (Freund & Anderson, 1996). Since we 
used intact, fresh-frozen brain tissue, it is possible that glycine present in our 
sections might interfere with the binding of [3H]MK801 and therefore mask 
putative alterations present in samples from chronic alcohol consumers.  
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It might be considered that ethanol could interact with NMDA receptors in a 
manner not measurable by autoradiographic techniques. For instance, a 
decrease in specific NMDA receptor subunits could eventually be compensated 
by an accelerated synthesis of mRNA encoding the proteins involved.  Finally, it 
could be speculated that ethanol modifies other cellular events, such as the 
migration of receptor subunits from extrasynaptic sites in the plasmatic 
membrane to synaptic functional loci, or receptor assembly, among others. 
Thus, a number of fundamental questions remain open, and further studies on a 
greater number of human brain samples are necessary. Combined studies of 
histological assessment with autoradiography with different ligands and in situ 
hybridization can yield information on the effects of chronic ethanol 
consumption on functional mature NMDA receptors and some of their subunits.   
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Table 1. Densities of [3H]MK 801 binding in controls and alcohol consumers.  
Data are mean densities of specific [3H]MK 801 binding expressed in fmol/mg tissue (mean±SD). No statistically significant 
differences were found among the different groups. 
 
Group Frontal cortex Dentate gyrus CA1 
Controls 71.62 ± 17.89 (n=16) 147.83 ± 34.94 (n=15) 173.18 ± 49.65 (n=15) 
Alcohol consumers  (AC)  all 82.94 ± 20.57 (n=15) 139.26 ± 38.97 (n=13) 191.66 ± 70.19 (n=13) 
>80 g/day consumers 81.16 ± 16.25 (n=11) 131.28 ± 36.91 (n=11) 187.18 ± 75.94 (n=11) 
40-80 g/day consumers 87.86 ± 32.39 (n=4) 183.14 ± 6.92 (n=2) 216.29 ± 4.61 (n=2) 
Abstinents 79.71 ± 4.35 (n=3) 124.36 ± 18.93 (n=4) 165.75 ± 42.56 (n=4) 
Non-abstinents 83.75 ± 23.05 (n=12) 145.88 ± 44.53 (n=9) 203.17 ± 78.90 (n=9) 
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Figure I. Autoradiographic images showing the total (A) and non-specific (B) 
binding of [3H]MK801 in the hippocampus of a control subject. CA1: CA1 field; 
DG: dentate gyrus; PH: parahippocampal gyrus; wm: white matter. Bar= 4mm. 
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Supplementary Material  
Cases. Studies were performed on 32 Caucasian subjects, 16 chronic alcohol 
consumers (AC) and 16 psychiatrically normal controls. Data related to alcohol 
consumption were obtained from medical records and confirmed by reports 
from close family members. History of alcohol consumption including length of 
abstinence before death was registered. All AC selected had not been not 
previously diagnosed of any alcohol associated disorder. Consequently, none 
fulfilled any criteria of alcohol dependence (DSM-IV) or diseases associated to 
alcoholism (ICD-10). Patients with a known history of neurological or psychiatric 
disorders or intravenous drug abuse were excluded. Detailed information on the 
individual characteristics of subjects, including alcohol consumption data, is 
summarized in Supplementary Table 1. Storage time of tissues was in all cases 
lower than three years. One case died after a gastrointestinal haemorrhage but 
did not present alterations in mesenteric and portal circulation that could 
suggest that the bleeding was from hepatic origin, as observed at autopsy. 
 
Collection of brain samples and preparation for autoradiography. Brains 
were collected at autopsy at the Department of Pathology of the Hospital Clinic 
and the Forensic Anatomical Institute of Barcelona (Spain) within the first 28 
hours after death. A standardized neuropathological evaluation was done on 
formalin-fixed blocks of each brain. In the AC group, no anatomical evidences of 
Wernicke-Korsakoff syndrome were found.  
Once the brains were removed from the cranium, the right hemisphere was cut 
into approximately 2 cm-thick blocks, which were immediately frozen on dry ice 
and kept at -80ºC. Coronal sections (14 µm thick) were obtained from frozen 
blocks of frontal cortex and hippocampus using a microtome-cryostat (Leitz 
1720, Germany), thaw-mounted onto glass slides previously coated with APTS 
and kept at -20ºC until use. Experiments were run following a matched-pair 
design so that each pair included sections from one alcoholic brain and its 
matched control. 
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Supplementary material Table 1. Summary of cases 
 
Case  Age (years)  Sex 
PMI  
(hours) 
Alcohol 
(g/day)  Smoker
Ethanol  
abstinence 
before 
death 
Co‐
morbidity 
Pathological 
changes in 
necropsy 
Cause of 
death 
C1  45  M  23.5  None  Yes  –  –  – Accident 
C2  43  M  23.5  None  Yes  – –  – CHD 
C3  69  M  13.0  None  Yes  – –  – CRA 
C4  74  M  13.5  None  Yes  – CHD  –  PE 
C5  67  M  9.5  None  Yes  – –  –  CHD 
C6  47  M  16.0  None  Yes  – Hepatitis C + HT  –  CHD 
C7  59  M  6.0  None  None  – Pulmonar fibrosis  –  CRA 
C8  43  W  20.0  None  None  – –  ‐  Cancer 
C9  65  M  15.0  None  None  – –  Aortic aneurism  CHD 
C10  74  M  16.0  None  Yes  – CHD  –  CHD 
C11  47  M  16.0  None  None  – –  – CHD 
C12  72  M  20.0  None  Yes  – –  – CHD 
C13  66  W  22.0  None  Yes  – HT  –  CHD 
C14  59  M  12.0  None  Yes  – CHD  CHD  CHD 
C15  62  M  22.0  None  Yes  – CHD  CHD  CHD 
C16  70  M  19.0  None  Yes  – –  –  CHD 
     
A1  49  M  5.5  40‐80  No  NO  –  –  Traumatism 
A2  57  M  27.0  >80  No  NO  Tuberculosis –  CRA 
A3  44  M  21.0  >80  Yes  YES  COPD  –  CRA 
A4  67  M  16.0  >80  Yes  YES  –  Liver fibrosis  CRA 
A5  50  M  28.0  >80  No  NO  –  –  Sudden death 
A6  66  M  23.0  40‐80  Yes  NO  Diabetes mellitus  –  Sudden death 
A7  34  M  28.0  >80  None  NO  –  –  CRA 
A8  43  M  24.0  >80  Yes  NO  –  –  CRA 
A9  66  M  11.0  >80  None  NO  Diabetes mellitus  –  Traumatism 
A10  72  M  20.0  40‐80  Yes  NO  HT  –  CHD 
A11  74  M  24.5  40‐80  None  NO  –  Liver fibrosis  Sudden death 
A12  51  M  21.5  >80  Yes  NO  –  –  Sudden death 
A13  63  M  23.5  >80  None  NO  CHD  –  Sudden death 
A14  56  M  10.0  >80  Yes  YES  –  Liver fibrosis  CHD 
A15  73  M  14.0  >80  Yes  NO  COPD  –  GIH 
A16  64  M  6.0  >80  None  YES  –  –  CHD 
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(Supplementary table 1): A: Alcohol consumers; C: Controls; CHD: Coronary heart disease; 
COPD: Chronic obstructive pulmonary disease; CRA: Cardio‐respiratory arrest; GIH: 
Gastrointestinal hemorrhage; HC: Hepatic cirrhosis; HT: Hypertension; M: Man; PE: Pulmonary 
embolism.; PMI: Postmortem interval; W: Woman 
 
 
Quantitative receptor autoradiography for NMDA receptor binding. 
Incubation with [3H]MK-801 was performed as described previously (Gulya et 
al., 1991). For each brain block, three consecutive sections were used, two for 
the determination of total binding and one for the nonspecific binding. Slide-
mounted tissue sections were preincubated for 30 min in 50 mM Tris-HCl buffer 
(pH 7.4 at 25 ºC). Afterwards the slides were incubated for 120 min at 25 ºC in 
Tris-HCl buffer containing 20 nM [3H]MK801 (250.63 Ci/mmol; NEN DuPont, 
Boston, MA, USA). Nonspecific binding was determined in the presence of 2 µM 
unlabeled MK801. After incubation, the slides were given three 1-min rinses in 
Tris-HCl buffer. The sections were then rapidly dried under a stream of cold air.  
 
Autoradiograms were obtained by apposing the sections against 3H-sensitive 
film (Amersham Hyperfilm-[3H], Amersham, UK) for 5 weeks at 4 ºC. The film 
was co-exposed with sets of tritiated microscale standards (calibrated in nCi/mg 
tissue) (3H-Microscales, Amersham). The autoradiograms were developed and 
fixed with Kodak developer and fixer at 18 ºC. Sections were also stained with 
cresyl violet for anatomical reference and identification of the structures. 
 
The densities of [3H]MK801 binding were measured by microdensitometry in 
layers II-VI of the frontal cortex, the molecular layer of the gyrus dentatus, and 
oriens and pyramidal layers of the CA1 hippocampal field using a computerized 
image analysis system (MCID-M4, Imaging Researh Inc., St. Catharines, 
Ontario, Canada). Standardization curves derived from the tritiated standards 
were used to convert optical density readings of the autoradiograms into nCi/mg 
of tissue equivalents and transformed to fmol of bound [3H]MK801/mg protein. 
Non-specific binding was homogeneous and low in all regions. Images were 
enlarged ca. x20 with a zoom to obtain a resolution that could allow 
discriminating among hippocampal layers. Five measures were taken from each 
structure in every sample and the corresponding means were considered as 
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single density data points. The non-specific binding was subtracted from the 
mean of total binding densities obtained in duplicate sections.  
 
Statistical analysis. We used descriptive statistics with means and standard 
deviations for the baseline characteristics of the patients. Comparisons of 
binding densities between groups were done using the unpaired t-test, since the 
variables showed a normal distribution according to the results of the 
Kolmogorov-Smirnov test (GraphPad, Prism). All statistical tests were 2-tailed, 
and the significance level was 0.05.  
In order to rule out significant changes on binding data secondary to variables 
such as age, gender, PMI, storage time, alcohol consumption, hepatic fibrosis, 
benzodiazepine consumption, smoking history, sudden death, we performed a 
covariance analysis for the three regions studied (SPSS 14.0, SPSS Inc., 
Chicago, Illinois). 
 
Subject clinical data 
Covariance analysis of our data indicated that consumption low doses of 
benzodiazepines at night for sleeping disturbances reported for two cases, had 
no influence on binding data. According to this analysis there was an effect of 
sudden death on the statistical results which would need to be further 
confirmed.  
 
Alcohol abstinence: 
Several studies have shown that chronic ethanol ingestion produces increases 
in MK-801 binding to NMDA receptors in rat brain, and that the persistence of 
changes in MK-801 binding runs in parallel with the time-course for ethanol 
withdrawal seizure susceptibility, usually 24 hours (Gulya et al. 1991). In 
contrast, the human timing for the development of clinical withdrawal is more 
prolonged. The clinical manifestations can begin in a period between few hours 
and two days after alcohol cessation and then increment during the next days, 
when the patient can suffer severe symptomatology such as delirium tremens 
(MacKeon et al. 2008). Due to these chronologic differences between human 
and rodents, we considered alcohol consumers as non-abstinents when they 
had ingested alcohol less than 12 h before death, since it is unlikely that they 
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would undergo a withdrawal situation that could eventually involve acute 
changes in NMDA receptors.  
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